A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

October 20, 2021

Study Completion Date

October 20, 2021

Conditions
Arthritis, Psoriatic
Interventions
DRUG

Apremilast

Apremilast

Trial Locations (20)

8907

H Bellvitge, L'Hospitalet Del Llobregat

10600

H Virgen del Puerto, Cáceres

20014

H Donostia, Donostia / San Sebastian

25198

H Santa Maria Lleida, Lleida

30120

H Virgen de la Arrixaca, El Palmar

30202

H Santa Lucía, Murcia

31008

H Navarra, Pamplona

33012

H Monte Naranco, Oviedo

36213

Universitaire Vaudoise*, Vigo

38320

H Univ Canarias, Santa Cruz de Tenerife

43005

H Joan XXIII, Tarragona

07120b

H Son Espases, Mallorca

07198

H Son Llatzer, Mallorca

01009

H Txagorritxu de Vitoria, Vitoria-Gasteiz

08208

H Parc Tauli, Barcelona

06800

H Mérida, Badajoz

06010

H Perpetuo Socorro, Badajoz

08003

H Del Mar, Barcelona

07800

H Can Misses, Ibiza Town

08923

H l Esperit Sant, Santa Coloma de Gramenet

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY